Thierry Ng – NCARD

NCARD researchers discover blood markers that may predict mesothelioma treatment success

December 30, 2024

A groundbreaking study by researchers at the National Centre for Asbestos Related Diseases (NCARD), The Kids Research Institute and the Harry Perkins Institute of Medical Research has identified blood markers…

NCARD expands expertise to transform childhood cancer treatment

December 18, 2024

News

The National Centre for Asbestos Related Diseases (NCARD) is bringing its internationally recognised expertise in cancer immunotherapy to improve outcomes for children with cancer. In collaboration with Perth Children’s Hospital…

Why study with NCARD? Listen to the latest podcast on our postgraduate opportunities

December 11, 2024

News, Podcast

Located in Western Australia, home to one of the world’s highest rates of asbestos-related cancers, the National Centre for Asbestos-Related Diseases (NCARD) leads the way in mesothelioma research. At NCARD,…

NCARD Research Reveals Critical Support Needs for Mesothelioma Patients and Carers

December 9, 2024

News

A collaborative study by Curtin University’s Professor Lauren Breen and NCARD’s Professor Gary Lee has highlighted the unique psychosocial needs of mesothelioma patients and their caregivers. Published in Psycho-Oncology, the…

Targeting the brakes: A new approach to cancer treatment shows promise

November 20, 2024

News

We congratulate Dr Nicola Principe on her latest publication in the Journal for ImmunoTherapy of Cancer. This work, under the supervision of Dr Jonathan Chee, represents a collaborative effort involving…

NCARD study links immune cell types to survival in lung cancer and mesothelioma

October 28, 2024

News

Congratulations to Dr Linda Ye, a PhD student at the National Centre for Asbestos Related Diseases (NCARD), along with her supervisors, Associate Professor Alec Redwood, Prof Jenette Creaney and Prof…

Student research showcased at 2024 ASM and Public Lecture

October 18, 2024

News

Congratulations to our NCARD students on their impressive Three-Minute Thesis (3MT) presentations and poster displays at the 2024 Annual Scientific Meeting (ASM). At the ASM, students summarised their research in…

NCARD 2024 Annual Scientific Meeting – Public Lecture available online

October 4, 2024

Event, News

The 2024 NCARD Annual Scientific Meeting was held on September 18th and 19th at the Harry Perkins Building in QEII Medical Centre. The event included a Public Lecture on the…

Western Australia advances RNA cancer therapeutics: NCARD at the forefront

September 2, 2024

News

Western Australia has reinforced its leadership in RNA technology with the recent launch of the Australian Centre for RNA Therapeutics in Cancer (ACRTC). Supported by over $6 million in funding…

Don’t miss the 2024 NCARD Public Lecture!

August 23, 2024

Event

The 2024 NCARD Public Lecture: “Asbestos: New Frontiers in Management, Science, and Care” will be held on September 18. We have three speakers for the evening to discuss the latest…

NCARD researchers discover blood markers that may predict mesothelioma treatment success

NCARD expands expertise to transform childhood cancer treatment

Why study with NCARD? Listen to the latest podcast on our postgraduate opportunities

NCARD Research Reveals Critical Support Needs for Mesothelioma Patients and Carers

Targeting the brakes: A new approach to cancer treatment shows promise

NCARD study links immune cell types to survival in lung cancer and mesothelioma

Student research showcased at 2024 ASM and Public Lecture

NCARD 2024 Annual Scientific Meeting – Public Lecture available online

Western Australia advances RNA cancer therapeutics: NCARD at the forefront

Don’t miss the 2024 NCARD Public Lecture!

National Centre for Asbestos Related Diseases

Latest News

Recent Posts

Scientific Publications

Subscribe

Contacts